Litigation Details for TEVA PHARMACEUTICALS USA, INC. v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2014)
✉ Email this page to a colleague
TEVA PHARMACEUTICALS USA, INC. v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2014)
Docket | ⤷ Sign Up | Date Filed | 2014-10-07 |
Court | District Court, N.D. West Virginia | Date Terminated | 2017-06-27 |
Cause | 35:271 Patent Infringement | Assigned To | Irene Patricia Murphy Keeley |
Jury Demand | None | Referred To | |
Patents | 8,232,250; 8,399,413 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in TEVA PHARMACEUTICALS USA, INC. v. Mylan Pharmaceuticals Inc.
Details for TEVA PHARMACEUTICALS USA, INC. v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2014)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2014-10-07 | 1 | of United States Patent No. 8,232,250 (“the ’250 patent”) and United States Patent No. 8,399,413 (“the… #: 11 COUNT I FOR INFRINGEMENT OF U.S. PATENT NO. 8,232,250 BY DEFENDANTS 69. The allegations of the…DECLARATORY JUDGMENT OF INFRINGMENT OF U.S. PATENT NO. 8.232.250 BY DEFENDANTS 84. The allegations of the…copy of the ’250 patent is attached as Exhibit A. The ’413 Patent 53. The ’413 patent, entitled “Low … ’413 patent. 56. Teva Ltd. is the exclusive licensee of the ’413 patent. 57. The ’413 patent is listed | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |